Westwood Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-29,234
Closed -$728K 93
2025
Q4
$728K Buy
+29,234
New +$737K 0.55% 48
2023
Q3
Sell
-7,746
Closed -$284K 44
2023
Q2
$284K Hold
7,746
0.2% 38
2023
Q1
$316K Sell
7,746
-830
-10% -$35.8K 0.28% 39
2022
Q4
$439K Buy
8,576
+830
+11% +$39.8K 0.53% 30
2022
Q3
$339K Sell
7,746
-1,330
-15% -$64.6K 0.3% 35
2022
Q2
$476K Sell
9,076
-8,150
-47% -$415K 0.55% 25
2022
Q1
$892 Sell
17,226
-1,500
-8% -$77.8K 0.35% 32
2021
Q4
$1.11M Buy
+18,726
New +$928K 0.47% 28

Other funds holding PFE

Westwood Wealth Management's PFE Position: Q1 2026 in Review

Westwood Wealth Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 29,234 shares — an estimated $728K sold.

Westwood Wealth Management first reported a position in PFE in Q4 2021 and held it in 8 quarters. The position peaked at $1.11M in Q4 2021. 2,940 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Westwood Wealth Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Westwood Wealth Management sold 29,234 Pfizer shares in Q1 2026, an estimated $728K.
  • Westwood Wealth Management first reported a position in Pfizer in Q4 2021 and held it in 8 quarters.
  • Westwood Wealth Management's Pfizer position peaked at $1.11M in Q4 2021.
  • 2,940 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Westwood Wealth Management's 13F filing for Q1 2026, filed 11 May 2026.